DF-4 Lead Connector: Innovative Technology, Unexpected Problems and Novel Solutions.

Indian Pacing Electrophysiol J

Senior Consultant Cardiology, Medanta-The Medicity, Gurgaon, Delhi- NCR, Haryana, India.

Published: May 2014

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032777PMC
http://dx.doi.org/10.1016/s0972-6292(16)30751-3DOI Listing

Publication Analysis

Top Keywords

df-4 lead
4
lead connector
4
connector innovative
4
innovative technology
4
technology unexpected
4
unexpected problems
4
problems novel
4
novel solutions
4
df-4
1
connector
1

Similar Publications

The selection of an appropriate implantable cardioverter-defibrillator (ICD) type and implantation strategy involves a myriad of considerations. While transvenous ICDs are standard, the rise of non-transvenous options like subcutaneous ICDs and extravascular ICDs is notable for their lower complication rates. Historical preferences for dual chamber ICDs have shifted to single-chamber ICDs.

View Article and Find Full Text PDF
Article Synopsis
  • Left bundle branch area pacing (LBBAP) shows promise as a safe and effective alternative for cardiac resynchronization therapy (CRT) in patients with implantable cardioverter-defibrillators (ICD).
  • A study assessed the feasibility and safety of a traditional defibrillator lead in the LBBAP location, finding a 62.5% acute procedural success rate with some patients needing lead repositioning.
  • Follow-up results for an average of 3.8 months indicated stable pacing parameters with no inappropriate arrhythmia detection or therapy issues, supporting LBBAP as a viable option.*
View Article and Find Full Text PDF

The DF-4 defibrillator standard has been rapidly adopted due to its convenience at implantation. There are however trade-offs compared to the traditional DF-1 standard that are underappreciated. This viewpoint outlines the advantages and limitations of current defibrillator lead standards that should be kept in mind, as they impact the options that are available to deal with issues that may arise.

View Article and Find Full Text PDF

Initial Experience With Intercostal Insertion of an Extravascular ICD Lead Compatible With Existing Pulse Generators.

Circ Arrhythm Electrophysiol

August 2023

Cardiovascular Department, Sanatorio Italiano, Asunción, Paraguay (A.E.).

Background: This study assessed safety and feasibility of a novel extravascular implantable cardioverter defibrillator (ICD) lead when inserted anteriorly through a rib space and connected to various commercially available ICD pulse generators (PGs) placed in either a left mid-axillary or left pectoral pocket. Currently available or investigational, extravascular-ICDs include a subcutaneous or subxiphoid lead connected to customized extravascular-ICD PGs.

Methods: This novel extravascular-ICD (AtaCor Medical Inc, San Clemente, CA) employs a unique intercostal implant technique and is designed to function with commercial DF-4 ICD PGs.

View Article and Find Full Text PDF

Background: Diabetic nephropathy (DN), the most intractable complication in diabetes patients, can lead to proteinuria and progressive reduction of glomerular filtration rate (GFR), which seriously affects the quality of life of patients and is associated with high mortality. However, the lack of accurate key candidate genes makes diagnosis of DN very difficult. This study aimed to identify new potential candidate genes for DN using bioinformatics, and elucidated the mechanism of DN at the cellular transcriptional level.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!